Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1974 May;5(5):453–457. doi: 10.1128/aac.5.5.453

Synergistic Effect of Pactamycin and Sparsomycin on Mycoplasma-Induced Lethal Toxicity of Mice

Michael G Gabridge 1
PMCID: PMC428993  PMID: 4471651

Abstract

Pactamycin and sparsomycin, antitumor drugs which act synergistically with endotoxins, also potentiate the lethal toxicity of mice by Mycoplasma fermentans, strain K10. Sparsomycin (50 μg/20 g mouse, injected intraperitoneally 1 h after various doses of M. fermentans) exerted a minimal degree of synergism with few extra deaths, but with prolonged appearance of nonlethal disease. Pactamycin (75 μg in the same protocol) increased susceptibility to Mycoplasma-induced lethal toxicity approximately 1,000-fold. The optimal response was noted when pactamycin was administered in the period between 6 h before and 3 h after the administration of 108 colony-forming units of viable mycoplasmas. Doses of 12.5, 25, or 50 μg increased severity of signs, but only 75 μg/mouse produced synergism of the lethal effect. Methylprednisolone partially negated the synergism when injected simultaneously with the pactamycin 1 h after the cells. The lethal synergistic effect occurred with four species of Mycoplasma in addition to M. fermentans.

Full text

PDF
453

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradley S. G., Rose W. C. Enhanced toxicity for mice of pactamycin with bacterial endotoxin. Antimicrob Agents Chemother. 1973 Jun;3(6):686–692. doi: 10.1128/aac.3.6.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gabridge M. G., Abrams G. D., Murphy W. H. Lethal toxicity of Mycoplasma fermentans for mice. J Infect Dis. 1972 Feb;125(2):153–160. doi: 10.1093/infdis/125.2.153. [DOI] [PubMed] [Google Scholar]
  3. Gabridge M. G., Murphy W. H. Toxic membrane fractions from Mycoplasma fermentans. Infect Immun. 1971 Dec;4(6):678–682. doi: 10.1128/iai.4.6.678-682.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hayflick L. Tissue cultures and mycoplasmas. Tex Rep Biol Med. 1965 Jun;23(Suppl):285+–285+. [PubMed] [Google Scholar]
  5. Marecki N. M., Bradley S. G. Enhanced toxicity for mice of combinations of bacterial endotoxin with antitumor drugs. Antimicrob Agents Chemother. 1973 May;3(5):599–606. doi: 10.1128/aac.3.5.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Murphy W. H., Bullis C., Ertel I. J., Zarafonetis C. J. Mycoplasma studies of human leukemia. Ann N Y Acad Sci. 1967 Jul 28;143(1):544–556. doi: 10.1111/j.1749-6632.1967.tb27701.x. [DOI] [PubMed] [Google Scholar]
  7. Pieroni R. E., Broderick E. J., Bundeally A., Levine L. A simple method for the quantitation of submicrogram amounts of bacterial endotoxin. Proc Soc Exp Biol Med. 1970 Mar;133(3):790–794. doi: 10.3181/00379727-133-34565. [DOI] [PubMed] [Google Scholar]
  8. Rose W. C., Bradley S. G. Enhanced toxicity for mice of combinations of antibiotics with Escherichia coli cells or Salmonella typhosa endotoxin. Infect Immun. 1971 Nov;4(5):550–555. doi: 10.1128/iai.4.5.550-555.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rose W. C., Bradley S. G., Lee I. P. Potentiation of the toxicity of several antitumor agents by Salmonella typhosa endotoxin. Toxicol Appl Pharmacol. 1972 Sep;23(1):102–111. doi: 10.1016/0041-008x(72)90209-8. [DOI] [PubMed] [Google Scholar]
  10. Rose W. C., Bradley S. G. Retardation by methylprednisolone of the synergistic toxicity of endotoxin with sparsomycin or pactamycin. Proc Soc Exp Biol Med. 1969 Nov;132(2):729–731. doi: 10.3181/00379727-132-34298. [DOI] [PubMed] [Google Scholar]
  11. Tada K., Trakatellis A. C. Mechanism of action of sparsomycin on protein synthesis. Antimicrob Agents Chemother (Bethesda) 1970;10:227–230. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES